Pharma
Samsung, Massachusetts General Hospital team up to study GLP-1 muscle loss
Galaxy Watch wearers will get alerts about health and exercise to see if they can maintain their strength.
Therapeutic Areas & Drug Cases
In-depth reporting on therapeutic areas & drug cases, from market shifts and clinical breakthroughs to the essential updates shaping the sector.
Pharma
How Eli Lilly’s oral GLP-1 could change the obesity drug market
A hot new GLP-1 bombshell has entered the villa.
Pharma
Pfizer, Novo Nordisk bidding war is just the latest escalation of a lucrative GLP-1 race
The G in GLP-1 might as well stand for gold.
Pharma
Healthcare execs on the state of psychedelic medicine
While there’s still a long way to go, the industry is starting to embrace psychedelics.
Pharma
Serena Williams as Ro’s celeb ambassador could mark ‘a big shift’ in pharma advertising
Pharma isn’t known for big-name celebrity appearances, but Ro’s approach could change the landscape.
Pharma
What’s the difference between the GLP-1s on the market?
From semaglutide vs. tirzepatide to Ozempic vs. Wegovy.
Pharma
Eli Lilly, Novo Nordisk report strong earnings as GLP-1 race heats up
Both drugmakers saw strong YoY sales, though Novo’s GLP-1 sales were down slightly from Q4 2024.
Navigate the healthcare industry
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
By subscribing, you accept our Terms & Privacy Policy.
